Wei Binxian bought PALI
June 10, 2026 · Form 4 insider transaction
Wei Binxian bought 20,200 shares of Palisade Bio, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,200
Price
N/A
Total value
N/A
InsiderWei Binxian
Role—
CompanyPalisade Bio, Inc. (PALI)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 10, 2026
Filing dateJune 12, 2026
Shares owned after613,355
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026.